BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30497938)

  • 1. Impact on treatment time of MRI-based brachytherapy in two implants (4 doses) compared with CT-based brachytherapy in five implants for cervical cancer.
    Small C; Harmon G; Weaver J; Vivirito V; Durazo-Arvizu R; Small W; Harkenrider MM
    Brachytherapy; 2019; 18(2):141-145. PubMed ID: 30497938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
    Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
    Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of computed tomography with magnetic resonance imaging for imaging-based clinical target volume contours in cervical cancer brachytherapy.
    Zolciak-Siwinska A; Kowalczyk A; Sikorska K; Bijok M; Michalski W; Gruszczynska E
    Brachytherapy; 2018; 17(4):667-672. PubMed ID: 29764769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Outcomes of Computed Tomography-Based Volumetric Brachytherapy Planning for Cervical Cancer.
    Simpson DR; Scanderbeg DJ; Carmona R; McMurtrie RM; Einck J; Mell LK; McHale MT; Saenz CC; Plaxe SC; Harrison T; Mundt AJ; Yashar CM
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):150-7. PubMed ID: 26130230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel use of ViewRay MRI guidance for high-dose-rate brachytherapy in the treatment of cervical cancer.
    Ko HC; Huang JY; Miller JR; Das RK; Wallace CR; De Costa AA; Francis DM; Straub MR; Anderson BM; Bradley KA
    Brachytherapy; 2018; 17(4):680-688. PubMed ID: 29773331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid (CT/MRI based) vs. MRI only based image-guided brachytherapy in cervical cancer: Dosimetry comparisons and clinical outcome.
    Choong ES; Bownes P; Musunuru HB; Rodda S; Richardson C; Al-Qaisieh B; Swift S; Orton J; Cooper R
    Brachytherapy; 2016; 15(1):40-8. PubMed ID: 26602964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional high dose rate intracavitary image-guided brachytherapy for the treatment of cervical cancer using a hybrid magnetic resonance imaging/computed tomography approach: feasibility and early results.
    Beriwal S; Kannan N; Kim H; Houser C; Mogus R; Sukumvanich P; Olawaiye A; Richard S; Kelley JL; Edwards RP; Krivak TC
    Clin Oncol (R Coll Radiol); 2011 Dec; 23(10):685-90. PubMed ID: 21908180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Medicare cost analysis of MRI- versus CT-based high-dose-rate brachytherapy of the cervix: Can MRI-based planning be less costly?
    Bajaj A; Harmon G; Weaver J; Martin B; Mysz M; Surucu M; Roeske JC; Konski AA; Small W; Harkenrider MM
    Brachytherapy; 2018; 17(2):326-333. PubMed ID: 29331574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of computed tomography and magnetic resonance imaging in cervical cancer brachytherapy target and normal tissue contouring.
    Eskander RN; Scanderbeg D; Saenz CC; Brown M; Yashar C
    Int J Gynecol Cancer; 2010 Jan; 20(1):47-53. PubMed ID: 20130502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of offline adaptive planning techniques in image-guided brachytherapy of cervical cancer.
    Liu H; Kinard J; Maurer J; Shang Q; Vanderstraeten C; Hayes L; Sintay B; Wiant D
    J Appl Clin Med Phys; 2018 Nov; 19(6):316-322. PubMed ID: 30284370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer brachytherapy in Canada: A focus on interstitial brachytherapy utilization.
    Taggar AS; Phan T; Traptow L; Banerjee R; Doll CM
    Brachytherapy; 2017; 16(1):161-166. PubMed ID: 27914911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can MRI-only replace MRI-CT planning with a titanium tandem and ovoid applicator?
    Harkenrider MM; Patel R; Surucu M; Chinsky B; Mysz ML; Wood A; Ryan K; Shea SM; Small W; Roeske JC
    Brachytherapy; 2018; 17(5):747-752. PubMed ID: 29945764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer.
    Tanderup K; Fokdal LU; Sturdza A; Haie-Meder C; Mazeron R; van Limbergen E; Jürgenliemk-Schulz I; Petric P; Hoskin P; Dörr W; Bentzen SM; Kirisits C; Lindegaard JC; Pötter R
    Radiother Oncol; 2016 Sep; 120(3):441-446. PubMed ID: 27350396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?
    Mazeron R; Petit C; Rivin E; Limkin E; Dumas I; Maroun P; Annede P; Martinetti F; Seisen T; Lefkopoulos D; Chargari C; Haie-Meder C
    Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):171-7. PubMed ID: 26547694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early clinical outcomes of ultrasound-guided CT-planned high-dose-rate interstitial brachytherapy for primary locally advanced cervical cancer.
    Mesko S; Swamy U; Park SJ; Borja L; Wang J; Demanes DJ; Kamrava M
    Brachytherapy; 2015; 14(5):626-32. PubMed ID: 26024784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Functional Magnetic Resonance Imaging in Cervical Cancer Patients With Incomplete Response on Positron Emission Tomography/Computed Tomography After Image-Based High-Dose-Rate Brachytherapy.
    Kalash R; Glaser SM; Rangaswamy B; Horne ZD; Kim H; Houser C; Beriwal S
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1008-1013. PubMed ID: 29559287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change in image-guided planning strategies over time impacts oncologic and survival outcomes for intracavitary cervical cancer brachytherapy.
    D'Cunha P; Gonzalez Y; Nwachukwu C; Hrycushko B; Medin P; Owrangi A; Jia X; Albuquerque K
    Brachytherapy; 2022; 21(5):668-677. PubMed ID: 35871130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bladder distension on doses to organs at risk in Pulsed-Dose-Rate 3D image-guided adaptive brachytherapy for locally advanced cervical cancer.
    Nesseler JP; Charra-Brunaud C; Salleron J; Py JF; Huertas A; Meknaci E; Courrech F; Peiffert D; Renard-Oldrini S
    Brachytherapy; 2017; 16(5):976-980. PubMed ID: 28694116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI-based preplanning using CT and MRI data fusion in patients with cervical cancer treated with 3D-based brachytherapy: feasibility and accuracy study.
    Dolezel M; Odrazka K; Zizka J; Vanasek J; Kohlova T; Kroulik T; Spitzer D; Ryska P; Tichy M; Kostal M; Jalcova L
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):146-52. PubMed ID: 22300570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.